Scarica l'app Stockscreener
6.79
3.35%
0.22
Dopo l'orario di chiusura:
6.91
0.12
+1.77%
Precedente Chiudi:
$6.57
Aprire:
$6.59
Volume 24 ore:
38,484
Relative Volume:
0.28
Capitalizzazione di mercato:
$3.48M
Reddito:
-
Utile/perdita netta:
$-17.06M
Rapporto P/E:
-0.096
EPS:
-70.7173
Flusso di cassa netto:
$-14.18M
1 W Prestazione:
-8.86%
1M Prestazione:
-35.32%
6M Prestazione:
-89.50%
1 anno Prestazione:
-92.30%
Intervallo 1D:
$6.32
$7.55
Intervallo di 1 settimana:
$6.2801
$7.55
Portata 52W:
$6.2801
$221.94
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Nome
Cns Pharmaceuticals Inc
Settore
Industria
Telefono
1-800-946-9185
Indirizzo
2100 WEST LOOP SOUTH, HOUSTON
Confronta CNSP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
6.79 | 3.48M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-12-28 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | Iniziato | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc Borsa (CNSP) Ultime notizie
CNS Pharmaceuticals CNSP 2025Q2 Earnings Preview Downside Risk Amid Market Uncertainties - AInvest
Central Nervous System (CNS) Therapeutics Market Forecast - openPR.com
What analysts say about CNS Pharmaceuticals Inc. stockGet alerts on high-potential market moves - Jammu Links News
Is CNS Pharmaceuticals Inc. stock overvalued or undervaluedRapid growth trajectories - Jammu Links News
Should I hold or sell CNS Pharmaceuticals Inc. stock in 2025Free Trend-Following Techniques - Jammu Links News
When is CNS Pharmaceuticals Inc. stock expected to show significant growthRapid-fire capital growth - Jammu Links News
CNS Pharmaceuticals Inc. Stock Analysis and ForecastPhenomenal capital gains - Jammu Links News
What catalysts could drive CNS Pharmaceuticals Inc. stock higher in 2025Maximize returns with strategic portfolio planning - Jammu Links News
Why is CNS Pharmaceuticals Inc. stock attracting strong analyst attentionDynamic profit expansion - Jammu Links News
What are analysts’ price targets for CNS Pharmaceuticals Inc. in the next 12 monthsAmplify your gains with low-risk picks - Jammu Links News
What is the risk reward ratio of investing in CNS Pharmaceuticals Inc. stockHigh-performance stocks for savvy investors - Jammu Links News
How volatile is CNS Pharmaceuticals Inc. stock compared to the marketBuild a portfolio that outperforms consistently - Jammu Links News
What is the dividend policy of CNS Pharmaceuticals Inc. stockFinancial News Outlook For 2025 - Jammu Links News
What makes CNS Pharmaceuticals Inc. stock price move sharplyMassive Upside Selection - beatles.ru
CNS Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySwing Setup With Technical Confirmation Explained - metal.it
How does CNS Pharmaceuticals Inc. compare to its industry peersBeginner Investor Watchlist For 2025 - Jammu Links News
Published on: 2025-07-28 14:09:47 - metal.it
Will CNS Pharmaceuticals Inc. outperform the market Free Buy Low Sell High Stock Watch - Newser
Is it the right time to buy CNS Pharmaceuticals Inc. stockHigh-yield investments - Jammu Links News
What makes CNS Pharmaceuticals Inc. stock price move sharply 2-Day Signal Watch with Forecast Outcome - metal.it
How strong is CNS Pharmaceuticals Inc. company’s balance sheetExplosive earnings growth - Jammu Links News
Does CNS Pharmaceuticals Inc. stock perform well during market downturnsUnprecedented market success - Jammu Links News
Published on: 2025-07-27 20:34:14 - Jammu Links News
What drives CNS Pharmaceuticals Inc. stock priceFree Stock Movement Tracking - Autocar Professional
Is CNS Pharmaceuticals Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
Why CNS Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - beatles.ru
CNS Pharmaceuticals Announces Reverse Stock Split - TipRanks
CNS Pharmaceuticals to Participate in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference - 富途牛牛
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured In Virtual Investor Summer Spotlight Conference - Barchart.com
CNS Pharmaceuticals CEO Shares Brain Cancer Treatment Vision at Investor Conference | CNSP Stock News - Stock Titan
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured in Virtual Investor Summer Spotlight Conference - The Globe and Mail
CNS Pharmaceuticals To Carry Out 1-for-12 Reverse Stock Split On July 22nd, 2025 - 富途牛牛
Cns Pharmaceuticals Inc Azioni (CNSP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):